Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
AbbVie history
AbbVie company history timeline
The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013.
April 2013 AbbVie releases its first branded product (Humira)
AbbVie is a research-based biopharmaceutical company. It spun off of Abbott Laboratories in 2013.
On June 20, 2014, Reuters reported that AbbVie had attempted to acquire Shire for $46.5 billion (£27.3 billion or £46.11 per share); however, this offer was rejected.
Humira was the world’s top-selling prescription drug in 2015, according to The New York Times.
March 2016 AbbVie gains new approvals for Imbruvica and Venclexta/Venclyxto
June 2016 FDA approves Humira to treat an immune-mediated disease that can impair vision
Raymond, N. (2017, June 9). AbbVie must pay $15 million in Depakote birth-defect trial: jury.
Bloomberg. (2017, June 5). AbbVie’s testosterone gel under microscope as first trial begins.
October 2017 FDA grants AbbVie priority review of investigational treatment for endometriosis management
Elejalde-Ruiz, A. (2018, February 9). AbbVie, facing thousands of lawsuits about its AndroGel testosterone supplement, notches a significant win.
November 2018 FDA grants accelerated approval for a treatment of newly diagnosed acute myeloid leukemia patients
But according to Fortune, other patents should protect AbbVie’s sales through 2022.
Rate how well AbbVie lives up to its initial vision.
AbbVie jobs
Do you work at AbbVie?
Is AbbVie's vision a big part of strategic planning?
AbbVie competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| AstraZeneca | 1999 | $25.9B | 76,100 | 432 |
| Merck | 1891 | $64.2B | 74,000 | 1,534 |
| Bristol-Myers Squibb | 1887 | $48.3B | 30,000 | 2,216 |
| Johnson & Johnson | 1886 | $88.8B | 134,500 | 1,970 |
| Eli Lilly and Company | 1876 | $45.0B | 33,625 | 789 |
| Pfizer | 1849 | $63.6B | 78,500 | 515 |
| Forest Laboratories | 1954 | $3.6B | 6,200 | - |
| Amgen | 1980 | $33.4B | 22,000 | 670 |
| Abbott | 1888 | $42.0B | 109,000 | 1,654 |
| Vicuron Pharmaceuticals | - | $21.0M | 200 | - |
AbbVie history FAQs
Zippia gives an in-depth look into the details of AbbVie, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AbbVie. The employee data is based on information from people who have self-reported their past or current employments at AbbVie. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AbbVie. The data presented on this page does not represent the view of AbbVie and its employees or that of Zippia.
AbbVie may also be known as or be related to AbbVie, AbbVie Inc, AbbVie Inc., Abbvie and Abbvie Inc.